Patients With Migraine Equal of /More Than 3 and Equal of/ Less Than 12 Migraine Attacks/4 Weeks for Each of the Last 6 Months Preceding the Screening
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Randomized,Double Blind, Placebo Controlled Study to Assess Efficacy,Safety and Tolerability of BGG492 in Migraine Prevention (NCT01617941) | Novartis Pharmaceuticals | 2016-05-01 |
Track Patients With Migraine Equal of /More Than 3 and Equal of/ Less Than 12 Migraine Attacks/4 Weeks for Each of the Last 6 Months Preceding the Screening automatically
Every clearance here is in the API, with alerts when new ones post.